Skip to main content

QALY - Quality Adjusted Life Years

NICE use QALYs to calculate the effectiveness of drugs. I heard tonight that someone aged 60 cannot have a QALY of more than 0.6 per year.

This sounds very wrong, but is not clear on the NICE site.

It may be this is the reason why NICE have been so difficult on revealing their formulae.

The challenge now is to get to the Truth.

Comments

Perry Barr Focus Team said…
John, it sounds like utter rubbish. A QALY is based on the quality of life. There is a problem when economists attempt to evaluate the worth of life on the basis of economic contribution. That used to happen in cost-benefit analysis.

The problem with QALYs is that they may value the life of a disabled person as of less quality than a fully abled person. They are also problematic when aggregated over a long time period. That may be the source of your rumour because it may be that some analysts assume that quality of life will decline with extended age. However future QALYs are also discounted - just the same as any future economic costs or benefits - and to assume declining quality of life seems to me to be double-counting. Indeed should a conventional discount rate be used?
Jon
1:29 pm
Post a Comment

Popular posts from this blog

Trudiagnostic change PACE leaderboard algorithm - was in position 40, now position 44 - does it matter?

Trudiagnostic have changed the way they handle the Rejuvenation Olympics Leaderboard algorithm. The result of this initially was that I was globally no 40 and have now dropped to 44. Trudiagnostic are a US company that get samples of blood and they look at the DNA to see which parts of the DNA have methyl groups (CH3) attached to them. These modifications to DNA are called methylation markers. DunedinPACE is an algorithm which uses DNA methylation markers in white blood cells to work out how quickly or slowly someone is aging. I had three results on this. The odd thing about the results was that whilst my epigenetic age calculated from the same methylation markers was going down, the speed at which I was aging was going up. I find this somewhat counterintuitive. It is, however, I think relevant that in a global contest my approach on biochemistry which is quite different to many other people's does seem to keep up with others working in the same area. To that extent it...
Post a Comment
Read more